Procurement Summary
Country : Czech Republic
Summary : Medicinal Product of Atc Group N02cd01 with the Active Substance Erenumab
Deadline : 17 Jun 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 101235727
Document Ref. No. : 287578-2024
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : CZK 16711705
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
The subject of the performance of the public contract is the provision of continuous supplies of medicinal products of the ATC group N02CD01 with the active substance Erenumab in accordance with the technical requirements of the contracting authority and with the contractual and other conditions specified in the procurement documentation.
This is the provision of continuous supplies of the subject
Document Type: Contract Notice
Reference Number: 1
Contract Type: supplies
Estimated Value: 16711705 - CZK
Authority Type: body-pl-cga
Doc Title: Medicinal product of ATC group N02CD01 with active ingredient ERENUMAB
Dispatch Date: 2024- 05-14
Publish Date: 2024-05-15
Submission Date: 2024-06-17
Documents
Tender Notice